Share Buyback

Search documents
ISS increases its share buyback programme by DKK 500 million and commences second tranche
Globenewswire· 2025-08-12 05:31
Core Viewpoint - ISS A/S has increased its share buyback programme by DKK 500 million, now totaling up to DKK 3,000 million, to redistribute excess cash to shareholders and meet obligations from share-based incentive programmes [1][2][4]. Group 1: Share Buyback Programme Details - The second tranche of the share buyback programme will be up to DKK 1,750 million, commencing today and concluding by 13 February 2026 [1][4]. - The first tranche of approximately DKK 1,250 million was completed on 8 August 2025 [4]. - The programme is authorized to acquire treasury shares up to 15% of ISS' share capital [2]. Group 2: Regulatory Compliance - The share buyback programme is conducted in accordance with the Market Abuse Regulation and the Safe Harbour Regulation [3]. Group 3: Operational Framework - The maximum total consideration for shares to be bought back is up to DKK 3,000 million, with a maximum nominal value of shares to be acquired being DKK 22 million [6]. - Shares may be purchased on Nasdaq Copenhagen and other trading venues, with daily purchase limits set at 25% of the average daily trading volume over the preceding 20 days [6]. - The purchase price for treasury shares must not deviate by more than 10% from the quoted price at the time of acquisition [6]. Group 4: Company Overview - ISS is a global provider of workplace and facility service solutions, employing 325,000 individuals and generating DKK 83.7 billion in revenue in 2024 [5][7].
Brighthouse Financial Q2 Earnings Miss Estimates on Lower Premiums
ZACKS· 2025-08-08 17:01
Core Insights - Brighthouse Financial, Inc. (BHF) reported second-quarter 2025 adjusted earnings of $3.43 per share, missing the Zacks Consensus Estimate by 27% and reflecting a year-over-year decline of 38.4% [1][9] - The lower-than-expected results were attributed to reduced premiums and lower net investment income, although total expenses decreased significantly [1][9] Financial Performance - Total operating revenues for the quarter were $2.2 billion, down 2.9% year over year, primarily due to lower universal life and investment-type product policy fees and net investment income, missing the consensus estimate by 2.1% [2] - Premiums amounted to $166 million, an 8.3% decrease year over year, falling short of the Zacks consensus estimate of $200 million [2] - Adjusted net investment income was $1.3 billion, down 1.8% year over year, mainly due to lower income from alternative investments, with an investment income yield of 4.28% [3] - Total expenses were $778 million, a nearly 45% decrease from $1.4 billion year over year, which partially offset the revenue decline [3] Segment Performance - Annuities generated an adjusted operating income of $332 million, remaining flat year over year, with annuity sales increasing 8.4% to $2.6 billion, driven by stronger fixed annuity sales [4] - Life insurance segment reported an adjusted operating loss of $26 million compared to earnings of $42 million in the prior year, with life insurance sales increasing 17.8% quarter over quarter to $33 million [5] - The Run-off segment recorded an adjusted operating loss of $83 million, wider than the previous year's loss of $30 million, while Corporate & Other had an adjusted operating loss of $25 million compared to earnings of $2 million in the prior year [6] Financial Position - Cash and cash equivalents increased by 24.7% year over year to $5.5 billion, while shareholders' equity rose 37% to $5.7 billion [7] - Book value per share, excluding accumulated other comprehensive income, was $144.09 as of June 30, 2025, reflecting a 12.3% year-over-year increase [7] - Statutory combined total adjusted capital was $5.6 billion as of June 30, 2025, up 3.7% year over year [7] - The estimated combined risk-based capital ratio was in the range of 405-425% as of June 30, 2025 [8] Share Buyback Program - Brighthouse Financial repurchased shares worth $43 million in the second quarter of 2025, bringing the year-to-date total to $102 million [10]
Airbnb increases buyback by $6 billion
CNBC Television· 2025-08-06 22:34
Again, let's start with Airbnb. Those shares moving higher, up about 2% in the after hours after beating on the top and bottom line. EPS coming in at a$13 cents ahead of the 93 cents expected.Revenue also a slight beat, 3.1% billion against the 3.04% billion street estimate thanks to solid growth in nightst. Now, gross booking value, which reflects what hosts are earning, that was a standout at 23.5% billion, beating expectations of 22.7% billion. Nights booked on Airbnb accelerated from April to July.And t ...
Chatham Lodging Trust(CLDT) - 2025 Q2 - Earnings Call Transcript
2025-08-06 15:00
Financial Data and Key Metrics Changes - The company reported Q2 2025 hotel EBITDA of $30.9 million and adjusted EBITDA of $28.5 million, with adjusted FFO of $0.36 per share [24] - The GOP margin for the quarter was 46.3%, up 30 basis points from Q2 2024, attributed to strong expense control and moderating inflationary pressures [24] - Leverage was reduced to 3.5 times net debt to EBITDA as of June 30, enhancing financial flexibility [25] Business Line Data and Key Metrics Changes - The core business segment, Business Traveler, showed healthy growth with the highest occupancies during the week, outperforming industry RevPAR growth for 14 consecutive quarters [9] - RevPAR growth at the four Silicon Valley hotels was up 3%, with hotel EBITDA increasing by 3% to nearly $5 million [17] - The six predominantly leisure hotels accounted for about 20% of EBITDA, with RevPAR surging 4% when excluding the Portsmouth Hilton Garden Inn under renovation [19] Market Data and Key Metrics Changes - Silicon Valley's recovery to pre-pandemic levels was noted, with occupancy reaching 80% across four hotels [9] - The Sunbelt markets performed well, particularly Charleston and Florida, which experienced RevPAR growth after previous declines [11] - The Austin market faced challenges with RevPAR down 6% year-to-date and 14% in the quarter due to convention center closures [11] Company Strategy and Development Direction - The company completed the sale of five hotels for proceeds of $83 million, using the funds for development, acquisitions, and share repurchases [5] - A $25 million share buyback plan was approved, with approximately 20,000 shares repurchased at a weighted average price of $7.2 [5] - The company plans to launch an upsized syndication of its credit facility and term loan to enhance financial conditions and lower borrowing costs [6] Management Comments on Operating Environment and Future Outlook - Management expressed optimism about future performance, citing strong GDP growth rates and significant investments in technology and AI as positive indicators [14][15] - The company anticipates continued demand growth in Silicon Valley, supported by tech company investments and expansion [10] - Despite challenges in certain markets, management believes the overall industry is poised for better performance in the coming years [13] Other Important Information - The company spent approximately $9 million on CapEx in the quarter, adding eight rooms to the existing portfolio [22][23] - The company highlighted the importance of monitoring productivity closely, especially in labor and benefits, which are the largest expenses [21] Q&A Session Summary Question: Regarding asset recycling and the two additional hotels for sale - Management confirmed that one hotel is an older lower RevPAR asset, while the other is an opportunistic transaction to minimize capital requirements [28][29] Question: Timeline for development in Portland and acquisition opportunities - The development in Portland is expected to have a construction timeline of around 21 to 24 months, with a potential start within the next six months [30] - Management noted ongoing discussions in the acquisition market, with a wide bid-ask scenario but confidence that the gap will lessen over time [31]
Advantage Energy (AAVV.F) Earnings Call Presentation
2025-08-06 11:00
A Progressive Montney Producer for the New Energy Market Investor Presentation August 2025 Cautionary Statements / Advisory This presentation contains forward-looking information and specified financial measures such as non-GAAP financial measures, non-GAAP ratios, capital management measures and supplementary financial measures. Readers are advised to read this presentation in conjunction with the advisories contained at the end of this presentation (see "Advisories") and the footnotes contained on page 35 ...
FIS Q2 Earnings Meet Estimates on Strong Banking Solutions Unit
ZACKS· 2025-08-05 20:01
Core Insights - Fidelity National Information Services, Inc. (FIS) reported Q2 2025 adjusted EPS of $1.36, aligning with estimates and within the projected range of $1.34-$1.38, maintaining year-over-year consistency [1][10] - Revenues reached $2.6 billion, a 5.2% year-over-year increase, exceeding management's expectations and consensus estimates [1][10] Financial Performance - The quarterly results were bolstered by strong performances in Banking Solutions and Capital Market Solutions, with robust recurring revenues and a decline in SG&A expenses [2] - Cost of revenues increased by 7.6% year over year to $1.7 billion, while SG&A expenses decreased by 6.1% to $572 million, although higher than estimates [3] - Adjusted EBITDA rose 4.7% year over year to $1 billion, with a stable margin of 39.8% [4][10] Segment Performance - Banking Solutions generated $1.8 billion in revenues, a 6% year-over-year growth, surpassing estimates, though adjusted EBITDA margin decreased by 70 basis points to 43.6% [5] - Capital Market Solutions saw revenues increase by 6% to $765 million, also exceeding estimates, with an adjusted EBITDA margin of 50.3%, down 53 basis points [6] - The Corporate and Other segment reported revenues of $43 million, a 25% year-over-year decline, but still beating estimates, with an adjusted EBITDA loss of $133 million [7] Financial Position - As of June 30, 2025, FIS had cash and cash equivalents of $581 million, down 30.3% from the end of 2024, with total assets decreasing to $33.4 billion [8] - Long-term debt, excluding the current portion, was $8.9 billion, down from $9.7 billion at the end of 2024, while total equity fell to $14.2 billion from $15.7 billion [9] Cash Flow and Shareholder Returns - Net cash from operations was $382 million, a 30% decline year over year, with adjusted free cash flows decreasing by 42.1% to $292 million [11] - FIS returned $459 million to shareholders through share buybacks of $246 million and dividends of $212 million, reaffirming a target of $1.2 billion in share buybacks for 2025 [12] Future Guidance - Management forecasts Q3 2025 revenues between $2.650 billion and $2.665 billion, with adjusted EBITDA projected at $1.105-$1.120 billion and adjusted EPS estimated between $1.46 and $1.50 [13] - For the full year 2025, revenues are expected to be in the range of $10.520-$10.570 billion, with adjusted EBITDA projected between $4.315 billion and $4.335 billion [14][15]
Fresenius Medical Care AG(FMS) - 2025 Q2 - Earnings Call Transcript
2025-08-05 13:00
Financial Data and Key Metrics Changes - The company achieved strong organic revenue growth of 7% in Q2 2025, with a 5% increase at constant currency [6][18] - Operating income grew by 13% on a constant currency basis, leading to a margin expansion to 9.9% [18][20] - Operating cash flow increased by 75%, and the net leverage ratio improved to 2.7 times, within the target range of 2.5 to 3 times [7][28] Business Line Data and Key Metrics Changes - Care Delivery in the U.S. showed organic growth of 3.4%, supported by favorable rate and payer mix, despite volume impacts from a severe flu season [22] - Internationally, Care Delivery achieved robust organic growth of 4.5%, driven by 1.7% same market treatment growth [23] - Value Based Care segment realized a strong organic revenue growth of 28%, primarily due to increased member months from expanded contracting [25] - Care Enablement reported a 3% revenue growth, with a significant 79% increase in operating income, leading to a margin increase of 380 basis points [26] Market Data and Key Metrics Changes - In the U.S., patient inflow dynamics improved, with five consecutive months of increasing referrals and new patient starts [15][46] - The severe flu season earlier in the year resulted in elevated mortality and mistreatments, impacting overall patient flow [16][60] Company Strategy and Development Direction - The company is focused on the "FME Reignite" strategy to enhance kidney care through exceptional patient care and innovation [5] - A share buyback program of €1 billion was announced, aimed at returning excess cash to shareholders [7][29] - The company is refining its operating model by separating Value Based Care as a distinct reporting segment to enhance financial transparency [12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving accelerating earnings development in the second half of 2025, despite current volume challenges [30][75] - The company expects to confirm its full-year outlook, projecting operating income growth in the high teens to high 20s percent range compared to the prior year [31][32] Other Important Information - The company plans to launch the 5,000 MADE X and high volume HDR in the U.S. clinics, with a rollout beginning in Q3 [11] - The impact of foreign exchange rates was noted, with a potential 3% to 4% headwind on revenue and earnings if current rates persist [106] Q&A Session Summary Question: U.S. Volume Growth and 2026 Outlook - Management indicated that while current mortality rates are elevated, they expect to see growth in U.S. volumes in 2026, supported by improving referral trends [38][40] Question: Care Enablement Margin Expansion - Management expressed optimism about continued margin expansion in Care Enablement, particularly in the second half of the year, which is typically stronger [41] Question: Patient Inflow Dynamics - Management noted that patient inflows have improved significantly, with the best trends seen in years, and emphasized the importance of both market conditions and internal processes [46][47] Question: Value Based Care Revenue Growth - Management confirmed strong revenue growth in Value Based Care, with expectations for continued strength in the second half, although operating income is expected to remain slightly negative to breakeven [52][56] Question: Phosphate Binders Contribution - Management indicated that phosphate binders contributed positively in H1, with expectations for continued support in the second half, although specific contributions were not quantified [67][82] Question: High Volume HDF Machine Rollout - The company is on track to convert 30 clinics and 600 machines during Q3 and Q4, with significant financial impacts expected in 2026 [103] Question: FX Headwind on EBIT - Management expects a 3% to 4% impact on both revenue and earnings from foreign exchange rates if current levels persist [106]
Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025
Prnewswire· 2025-08-05 11:00
Core Insights - Fresenius Medical Care AG reported strong operational performance in Q2 2025, with organic revenue growth of 7% and double-digit operating income growth, aligning with the company's full-year financial outlook [1][5][25] - The company experienced a 20% increase in net income for Q2 2025, reaching EUR 225 million, and a 46% increase in net income for H1 2025, totaling EUR 376 million [19][20] Financial Performance - Q2 2025 revenue was EUR 4,792 million, a 1% increase year-on-year, with a 5% increase at constant currency and a 7% organic growth [2][7] - Operating income for Q2 2025 remained stable at EUR 425 million, with a 13% increase in operating income excluding special items to EUR 476 million [13][18] - Basic earnings per share (EPS) increased by 20% to EUR 0.77 in Q2 2025, and by 46% to EUR 1.28 in H1 2025 [20][25] Strategic Initiatives - The FME25+ transformation program generated EUR 58 million in sustainable savings in Q2 2025, with a target of EUR 180 million in annual savings by year-end 2027 [3][5] - The company is executing a portfolio optimization plan to exit non-core assets, which is expected to negatively impact 2025 revenue growth by approximately 1% [4][12] Operational Highlights - Care Enablement revenue increased by 36% in Q2 2025, driven by higher volumes and positive pricing developments [16] - Value-Based Care revenue grew by 22% in Q2 2025, reflecting a significant increase in member months due to contract expansions [9][12] Cash Flow and Leverage - Operating cash flow improved by 75% to EUR 775 million in Q2 2025, with a net leverage ratio of 2.7x [21][23] - Free cash flow increased by 117% to EUR 628 million in Q2 2025 [22] Outlook - Fresenius Medical Care confirmed its fiscal 2025 outlook, expecting positive revenue growth in the low single digits and operating income growth excluding special items in the high teens to high twenties percentage range [25][26]
Shell CEO Wael Sawan: The bar is high for acquisitions and it's not currently cheap
CNBC Television· 2025-07-31 16:13
Welcome back. Shell's profit falling more than 20% since last quarter, but it still beat estimates. Shell also announcing another $3.5% billion share buyback over the next three months.It's the 15th straight quarter of buybacks above $3 billion. Joining us now to talk about the business is Shell CEO while San. It's great to have you back while nice to see you. >> Good to see you, Sarah.Thank you for having me. So, so what is I mean I know there are are things like the chemical closure and sort of uh noise g ...
Kinross reports strong 2025 second-quarter results
GlobeNewswire News Room· 2025-07-30 21:00
Core Viewpoint - Kinross Gold Corporation reported strong financial results for Q2 2025, achieving record free cash flow of approximately $650 million, driven by robust margins and operational performance, while also advancing development projects and returning capital to shareholders [1][4][18]. Return of Capital to Shareholders - The company has reactivated its share buyback program, repurchasing approximately $225 million in shares of a planned $500 million for the year, and has returned about $300 million in capital to shareholders year-to-date [5][22][23]. - Kinross is on track to return a minimum of $650 million to shareholders for the full year, including a minimum of $500 million in share repurchases [23]. Operations Highlights - Kinross produced 512,574 gold equivalent ounces in Q2 2025, a decrease from 535,338 ounces in Q2 2024, with production costs of $1,080 per ounce sold [8][13]. - The average realized gold price increased to $3,284 per ounce in Q2 2025, compared to $2,342 per ounce in Q2 2024, contributing to a revenue increase of 42% year-over-year to $1,728.5 million [14][18]. - Operating cash flow rose to $992.4 million, and attributable free cash flow increased by 87% to $646.6 million compared to Q2 2024 [17][18]. Development and Exploration Projects - The company is advancing several high-quality development and exploration projects, including the Great Bear AEX program and Round Mountain Phase X, with significant progress in drilling and engineering studies [6][30][34]. - At Round Mountain Phase X, over 4,500 meters of decline development has been completed, with strong drilling results indicating continued mineralization [34][35]. Financial and Operating Results - Reported net earnings for Q2 2025 were $530.7 million, or $0.43 per share, more than doubling from $210.9 million, or $0.17 per share, in Q2 2024 [18][19]. - Attributable all-in sustaining cost per gold equivalent ounce sold was $1,493 in Q2 2025, compared to $1,387 in Q2 2024 [17]. - As of June 30, 2025, Kinross had cash and cash equivalents of $1,136.5 million, significantly up from $694.6 million at the end of Q1 2025 [21].